Impact of Minimally Invasive Surfactant Therapy in Preterm Infants at 29-32 Weeks Gestation

Conclusions: Selective use of minimally invasive surfactant therapy at 29-32 weeks gestation permits a primary CPAP strategy to be pursued with a high rate of success, and a low risk of pneumothorax.Neonatology 2018;113:7-14
Source: Neonatology - Category: Perinatology & Neonatology Source Type: research